Day One Biopharmaceuticals, Inc. (DAWN)

Last Three Months

26-Jan-24 -- 25-Apr-24

Time Period:

Three Months
|
Year

($1.10M) Net Amount

Buy:	0	--
Sell:	($1.10M)	$15.24 - $16.11

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

13

0

1

+1

0

+2

0

+3

Two Year Chart

26-Apr-22 -- 25-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
20-Feb-24 6:14 PM View:	16-Feb-24 Option Sale ($116.11K)	Bender Jeremy Chief Executive Officer Director		Day One Biopharmaceuticals, Inc. - DAWN	1% 1.75M to 1.77M	0	0	--	--	Show Txns Hide Txns

20-Feb-24 6:36 PM View:	16-Feb-24 Option Sale ($40.65K)	York Charles N II COO, CFO and Secretary		Day One Biopharmaceuticals, Inc. - DAWN	3% 270.17K to 277.75K	0	0	--	--	Show Txns Hide Txns

20-Feb-24 6:48 PM View:	16-Feb-24 Option Sale ($49.43K)	Dubow Adam General Counsel		Day One Biopharmaceuticals, Inc. - DAWN	45% 11.43K to 16.59K	0	0	--	--	Show Txns Hide Txns

22-Apr-24 6:36 PM View:	18-Apr-24 Market Sale (Planned) ($160.16K)	Blackman Samuel C. HEAD OF R&D		Day One Biopharmaceuticals, Inc. - DAWN	(3%) 2.24M to 2.17M	0	($1.10M) (3%)	--	$15.24 - $16.11	Show Txns Hide Txns